Citation Impact
Citing Papers
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Oral cavity and oropharyngeal squamous cell carcinoma—an update
2015 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Head and neck squamous cell carcinoma
2020 Standout
Molecular Cloning and Characterization of an Aquaporin cDNA from Salivary, Lacrimal, and Respiratory Tissues
1995 StandoutNobel
The Third Intergroup Rhabdomyosarcoma Study.
1995 Standout
Nasopharyngeal carcinoma
2005 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?
2004
Cisplatin and radiotherapy in the management of locally advanced head and neck cancer
1993
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Combined postoperative radiotherapy and Weekly Cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial
1996
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
2016 Standout
Radiation therapy for intracranial germinoma: The case for limited volume treatment
1990
Thyroid Cancer in Childhood Cancer Survivors: A Detailed Evaluation of Radiation Dose Response and its Modifiers
2006
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
2003 Standout
Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck
2002
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24
1997
Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.
1998
Anaplastic thyroid carcinoma: A 50-year experience at a single institution
2001
Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer
1998 Standout
Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: The M. D. Anderson cancer center experience
1994
Treatment of head and neck cancer: the role of chemotherapy
1996
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
Treatment of Anaplastic Thyroid Carcinoma with Paclitaxel: Phase 2 Trial Using Ninety-Six-hour Infusion
2000
Toxicity in head and neck cancer: a review of trends and issues
2000
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
2009 Standout
Precisely defining high-risk operable head and neck tumors based on rtog #85-03 and #88-24: Targets for postoperative radiochemotherapy?
1998
Ethanol Decreases Natural Killer Cell Activation but Only Minimally Affects Anatomical Distribution After Administration of Polyinosinic:Polycytidylic Acid: Role in Resistance to B16F10 Melanoma
2003
Pineal region germinomas in childhood treatment considerations
1990
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
2009
Chemotherapy in locally advanced head and neck cancer: a critical reappraisal
1995
Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: Results from two randomized clinical trials
1993
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
2000 Standout
Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases
1997 Standout
Incidence of second primary tumours among childhood cancer survivors
1987
The chemoradiation paradigm in head and neck cancer
2007
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Postoperative accelerated radiotherapy in high-risk squamous cell carcinoma of the head and neck: Long-term results of a prospective trial
1998
The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: An analysis of 1301 patients
1994
Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip
1992 Standout
Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials.
1997
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience
2004
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
State-of-the-art management of locally advanced head and neck cancer
2005
An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer
1995
Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial
1993
Treatment results of intracranial germinoma as a function of the irradiated volume
1988
Head and Neck Cancer
1993 Standout
Anaplastic thyroid carcinoma: Current diagnosis and treatment
2000
Altered fractionation in the treatment of head and neck cancer
1999
Intracranial germ-cell tumors in children
1991
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
2009 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III Trial
1996 Standout
A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results
1997
Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma
1999 Standout
Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials.
1996
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
Head and Neck Cancer
2001 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
The 2007 WHO Classification of Tumours of the Central Nervous System
2007 Standout
Intracranial germ-cell tumors: natural history and pathogenesis
1985 Standout
Does Induction Chemotherapy Have a Role in the Management of Locoregionally Advanced Squamous Cell Head and Neck Cancer?
2006
Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial
2002
Head and Neck Cancer
2020 Standout
Synergistic Antitumor Activity of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib and IFN-α in Head and Neck Cancer Cells In vitro and In vivo
2006
Oligodendroglioma occurring after radiation therapy for pituitary adenoma.
1987
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck
1997
The Expanding Role of Systemic Therapy in Head and Neck Cancer
2004
Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
1996
The 2007 WHO Classification of Tumours of the Central Nervous System
2010 Standout
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
Inhibition of Toll-like Receptor and Cytokine Signaling—A Unifying Theme in Ischemic Tolerance
2004 StandoutNobel
Adjuvant Therapy in Patients With Resected Poor-Risk Head and Neck Cancer
2006
Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know
2003 Standout
Does Histologic Grade Have a Role in the Management of Head and Neck Cancers?
2001
INCIDENCE OF SECOND MALIGNANT NEOPLASMS IN CHILDREN: RESULTS OF AN INTERNATIONAL STUDY
1982
Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease
2001 Standout
Thyroid carcinoma
2003 Standout
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
2005 Standout
Works of Robert E. Haselow being referenced
Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report of intergroup study 0034
1992
Immunohistochemical analysis of small cell tumors of the thyroid gland: An eastern cooperative oncology group study
1992
Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study.
1993
The incidence of second neoplasms following megavoltage radiation for pediatric tumors
1985
Adjubant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on intergroup study 0034
1991
Pineal and ectopic pineal tumors: The role of radiation therapy
1981
Second neoplasms following megavoltage radiation in a pediatric population
1978
Phase II Trial of Interferon-?? in Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Immunological and Clinical Correlates
1996